Whitney Ijem
Stock Analyst at Canaccord Genuity
(3.35)
# 967
Out of 4,876 analysts
101
Total ratings
44.94%
Success rate
4.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics | Downgrades: Hold | $39 → $13 | $11.27 | +15.40% | 6 | Jun 17, 2025 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $9 → $11 | $2.44 | +350.82% | 10 | Jun 3, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $34 → $11 | $2.66 | +313.53% | 8 | Jun 3, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $74 → $54 | $9.91 | +444.90% | 6 | Jun 3, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $53 → $52 | $21.60 | +140.80% | 3 | May 16, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $68 → $66 | $14.42 | +357.70% | 6 | May 13, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $81 → $92 | $61.40 | +49.84% | 7 | Apr 8, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $385 → $390 | $317.00 | +23.03% | 8 | Mar 21, 2025 | |
| GBIO Generation Bio Co. | Maintains: Buy | $9 | $0.35 | +2,453.19% | 2 | Mar 17, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Buy | $18 → $6 | $0.67 | +800.23% | 6 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $121 → $136 | $37.59 | +261.80% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $408 → $424 | $444.38 | -4.59% | 8 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 | $0.34 | +3,708.97% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $148 → $150 | $17.43 | +760.59% | 3 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $84 | $54.77 | +53.37% | 8 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $108.78 | - | 2 | Jan 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $120 → $240 | $4.48 | +5,257.14% | 4 | Jul 23, 2019 |
Verve Therapeutics
Jun 17, 2025
Downgrades: Hold
Price Target: $39 → $13
Current: $11.27
Upside: +15.40%
Taysha Gene Therapies
Jun 3, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $2.44
Upside: +350.82%
Rocket Pharmaceuticals
Jun 3, 2025
Maintains: Buy
Price Target: $34 → $11
Current: $2.66
Upside: +313.53%
Intellia Therapeutics
Jun 3, 2025
Maintains: Buy
Price Target: $74 → $54
Current: $9.91
Upside: +444.90%
Palvella Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $53 → $52
Current: $21.60
Upside: +140.80%
Arcturus Therapeutics Holdings
May 13, 2025
Maintains: Buy
Price Target: $68 → $66
Current: $14.42
Upside: +357.70%
Rhythm Pharmaceuticals
Apr 8, 2025
Maintains: Buy
Price Target: $81 → $92
Current: $61.40
Upside: +49.84%
Alnylam Pharmaceuticals
Mar 21, 2025
Maintains: Buy
Price Target: $385 → $390
Current: $317.00
Upside: +23.03%
Generation Bio Co.
Mar 17, 2025
Maintains: Buy
Price Target: $9
Current: $0.35
Upside: +2,453.19%
Tenaya Therapeutics
Mar 13, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $0.67
Upside: +800.23%
Feb 18, 2025
Maintains: Buy
Price Target: $121 → $136
Current: $37.59
Upside: +261.80%
Feb 12, 2025
Upgrades: Hold
Price Target: $408 → $424
Current: $444.38
Upside: -4.59%
Nov 14, 2024
Maintains: Buy
Price Target: $13
Current: $0.34
Upside: +3,708.97%
Nov 7, 2024
Maintains: Buy
Price Target: $148 → $150
Current: $17.43
Upside: +760.59%
Oct 30, 2024
Maintains: Hold
Price Target: $93 → $84
Current: $54.77
Upside: +53.37%
Jan 21, 2020
Downgrades: Neutral
Price Target: n/a
Current: $108.78
Upside: -
Jul 23, 2019
Upgrades: Overweight
Price Target: $120 → $240
Current: $4.48
Upside: +5,257.14%